NCT01097967

Brief Summary

The study aims to observe the short term effect (3-month) of sleep disordered breathing (SDB) on cardiovascular parameters, heart rate variability, endothelial function and surrogate markers of atherosclerosis after acute cerebrovascular events (ACE). The long-term effect (6-24-month) of Continuous Positive Airway Pressure (CPAP) on clinical vascular outcome, cardiovascular parameters, evolution of surrogate of atherosclerosis heart rate variability and endothelial function after ACE is observed over 24 months. A preventive effect of CPAP therapy on cerebro-vascular events in patients with moderate-severe obstructive SDB without sleepiness after ictus or transient ischaemic attack will be evaluated.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
246

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jul 2010

Longer than P75 for phase_4

Geographic Reach
3 countries

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 2, 2010

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2010

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

October 26, 2015

Status Verified

October 1, 2015

Enrollment Period

5.8 years

First QC Date

April 1, 2010

Last Update Submit

October 23, 2015

Conditions

Keywords

Sleep disordered breathingContinuous Positive Airway PressureSleep apnoeaMarkers of atherosclerosis

Outcome Measures

Primary Outcomes (1)

  • Occurence of new vascular events or death in stroke survivors (myocardial infarction, stroke, death) assessed by telephone or reported

    New vascular events will be assessed by regular telephone interviews at 6,12 and 24 months after stroke

    24 monts after stroke

Secondary Outcomes (3)

  • CPAP-Compliance measured by hours of usage

    up to 24 months after stroke

  • Blood pressure profile (systolic mean, diastolic mean, max, min: general, day, night) measured in mmHg for every patient by ambulatory 24h-BP-devices in the acute stroke phase, after 3 months and after 12 months

    up to 12 months after stroke

  • Blood pressure dipping measured by ambulatory 24h-BP-devices in the acute stroke phase, after 3 months and after 12 months

    up to 12 months after stroke

Study Arms (3)

CPAP in sleepy patients with SDB

ACTIVE COMPARATOR

SDB defined as AHI \>=20 Sleepy defined as Epworth Sleepiness Score \>=10

Other: CPAP

no CPAP in non sleepy patients with SDB

NO INTERVENTION

SDB defined as AHI \>=20 Sleepy defined as Epworth Sleepiness Score \>=10

CPAP in non sleepy patients with SDB

ACTIVE COMPARATOR

SDB defined as AHI \>=20 Sleepy defined as Epworth Sleepiness Score \>=10

Other: CPAP

Interventions

CPAPOTHER
CPAP in non sleepy patients with SDBCPAP in sleepy patients with SDB

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 35 years old and \< 75 years old
  • with clinical diagnosis of TIA or ischemic stroke
  • admitted in a Stroke Unit within 2 days from onset of symptoms
  • or with TIA or ischemic stroke within the last 60-90 days
  • signed Informed Consent

You may not qualify if:

  • with unstable clinical situation (cardio-respiratory or life-threatening medical conditions)
  • currently on CPAP or on CPAP during the last 3 months before stroke
  • with non-ischemic events (intracerebral/subarachnoid haemorrhage)
  • Patients with coma/stupor
  • with borderline obstructive SDB (AHI 10-19)
  • with any condition that interferes with the acceptance of CPAP treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University Hospital Münster

Münster, Germany

Location

Dipartimento Neuroscienze, Ospedale Niguarda

Milan, Lombardy, I-20162, Italy

Location

Inselspital, Universitätsklinik für Pneumologie

Bern, Canton of Bern, CH-3010, Switzerland

Location

Ospedale San Giovanni

Bellinzona, Canton Ticino, CH-6500, Switzerland

Location

Neurocenter of Southern Switzerland, Ospedale Civico

Lugano, Canton Ticino, CH-6900, Switzerland

Location

Related Publications (8)

  • Bassetti C, Aldrich MS, Chervin RD, Quint D. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology. 1996 Nov;47(5):1167-73. doi: 10.1212/wnl.47.5.1167.

    PMID: 8909424BACKGROUND
  • Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1999 Mar 15;22(2):217-23. doi: 10.1093/sleep/22.2.217.

    PMID: 10201066BACKGROUND
  • Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 Mar 19-25;365(9464):1046-53. doi: 10.1016/S0140-6736(05)71141-7.

    PMID: 15781100BACKGROUND
  • Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke. 2006 Apr;37(4):967-72. doi: 10.1161/01.STR.0000208215.49243.c3. Epub 2006 Mar 16.

    PMID: 16543515BACKGROUND
  • Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L, Soriano Y, Roman-Sanchez P, Illa FB, Canal JM, Duran-Cantolla J. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med. 2009 Jul 1;180(1):36-41. doi: 10.1164/rccm.200808-1341OC. Epub 2009 Apr 30.

    PMID: 19406983BACKGROUND
  • Pace M, Camilo MR, Seiler A, Duss SB, Mathis J, Manconi M, Bassetti CL. Rapid eye movements sleep as a predictor of functional outcome after stroke: a translational study. Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy138.

  • Manconi M, Zavalko I, Cereda C, Pisarenco I, Ott S, Fulda S, Bassetti CL. Longitudinal polysomnographic assessment from acute to subacute phase in infratentorial versus supratentorial stroke. Cerebrovasc Dis. 2014;37(2):85-93. doi: 10.1159/000356323. Epub 2014 Jan 16.

  • Cereda CW, Petrini L, Azzola A, Ciccone A, Fischer U, Gallino A, Gyorik S, Gugger M, Mattis J, Lavie L, Limoni C, Nobili L, Manconi M, Ott S, Pons M, Bassetti CL. Sleep-disordered breathing in acute ischemic stroke and transient ischemic attack: effects on short- and long-term outcome and efficacy of treatment with continuous positive airways pressure--rationale and design of the SAS CARE study. Int J Stroke. 2012 Oct;7(7):597-603. doi: 10.1111/j.1747-4949.2012.00836.x. Epub 2012 Jul 19.

Related Links

MeSH Terms

Conditions

Ischemic StrokeSleep Apnea Syndromes

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake Disorders

Study Officials

  • Claudio Bassetti, Professor

    Universitätsspital Bern (Inselspital) und Universität Bern

    PRINCIPAL INVESTIGATOR
  • Carlo Cereda, Capo CLinica

    Neurocentre of Southern Switzerland, Ospedale Civico

    STUDY CHAIR
  • Sebastian Ott, MD

    Pneumology, University Hospital, Bern

    STUDY CHAIR
  • Lino Nobili, Prof. MD

    Neurology, Stroke Unit, Ospedale Niguarda, Milan, Italy

    STUDY CHAIR
  • Mauro Manconi, MD

    Neurocentre of Southern Switzerland, Ospedale Civico

    STUDY CHAIR
  • Peter Young, Prof. MD

    Universitätsklinik Münster, Zentrum für Schlafmedizin

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr. med. Claudio Bassetti

Study Record Dates

First Submitted

April 1, 2010

First Posted

April 2, 2010

Study Start

July 1, 2010

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

October 26, 2015

Record last verified: 2015-10

Locations